The global market for Pharmaceutical & Biotechnology IP Services was valued at US$ 8795 million in the year 2024 and is projected to reach a revised size of US$ 15699 million by 2031, growing at a CAGR of 8.6% during the forecast period.

Pharmaceutical & Biotechnology IP Services Market

The Pharmaceutical & Biotechnology Intellectual Property (IP) Services market encompasses a broad range of specialized legal, technical, and strategic services aimed at protecting and maximizing the value of innovations in life sciences. These services include patent prosecution, litigation, portfolio management, licensing, regulatory compliance, and due diligence, specifically tailored to the needs of pharmaceutical, biotechnology, and related healthcare sectors. By safeguarding proprietary technologies and enabling strategic monetization, IP service providers play a critical role in supporting research and development efforts while mitigating the risk of infringement and competition.

From a multi-dimensional and parameterized perspective, the market can be segmented based on service type, client type, and geographical coverage. Service types include patent prosecution, patent litigation, licensing and technology transfer, IP valuation, and regulatory advisory services. Clients range from early-stage biotech startups and mid-sized pharmaceutical firms to multinational life sciences corporations. Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and emerging markets, with further differentiation based on specialty areas such as biologics, small molecule drugs, diagnostics, and gene therapies. Each segment is parameterized by factors like service complexity, legal jurisdiction, and the technical depth required.

The industry value chain begins with upstream providers supplying highly specialized IP law expertise, scientific consulting, and data analytics platforms for patent landscape and freedom-to-operate analyses. Midstream firms, often law firms or boutique IP service providers, integrate these capabilities into comprehensive offerings including patent filings, portfolio management, licensing strategies, and litigation support. Downstream clients—pharmaceutical companies, biotechnology firms, and healthcare institutions—leverage these services to protect innovations, support regulatory submissions, and facilitate strategic partnerships or acquisitions. Collaborative relationships between IP service providers and research organizations enhance knowledge transfer and ensure alignment with scientific and business objectives.

Regarding cost and margin structures, service providers face significant investments in skilled personnel, scientific expertise, and technological infrastructure for patent analytics and legal management. Costs are typically dominated by attorney fees, scientific consulting, and database access, while administrative and operational expenses contribute a smaller proportion. Gross margins vary significantly depending on the service model: high-value litigation and licensing advisory services can achieve margins of 50–70%, whereas routine patent prosecution and portfolio management services generally yield 30–50%. The market benefits from high-value, project-based contracts and recurring service arrangements that enhance profitability and revenue stability.

Looking ahead, the Pharmaceutical & Biotechnology IP Services market is expected to grow steadily, driven by increasing global R&D investments, the rising complexity of drug development, and stricter IP enforcement across jurisdictions. Demand for specialized IP services in areas such as biologics, biosimilars, gene editing, and digital therapeutics is rising, pushing providers to expand technical expertise and global coverage. Integration of AI and data analytics into patent strategy, portfolio optimization, and prior art searches is becoming a key differentiator. Overall, the market remains highly specialized, knowledge-intensive, and resilient, with sustainable growth prospects linked to innovation trends in the life sciences industry.

This report aims to provide a comprehensive presentation of the global market for Pharmaceutical & Biotechnology IP Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical & Biotechnology IP Services.

The Pharmaceutical & Biotechnology IP Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical & Biotechnology IP Services market comprehensively. Regional market sizes, concerning products by Type, by Application, by Technology Focus and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pharmaceutical & Biotechnology IP Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Pharmaceutical & Biotechnology IP Services Market Report

Report Metric	Details
Report Name	Pharmaceutical & Biotechnology IP Services Market
Accounted market size in year	US$ 8795 million
Forecasted market size in 2031	US$ 15699 million
CAGR	8.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Patents Copyrights Trademarks Others
Segment by Technology Focus	Small Molecule Drugs Biologics Biosimilars Gene Therapies Diagnostics Vaccines Others
Segment by Engagement Model	Project-based Petainer-based Others
Segment by Complexity and Technical Depth	Basic IP Services Advanced IP Services
Segment by Application	Pharmaceutical Companies Contract Research Organizations (CROs) Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Finnegan, MBHB, Wolf Greenfield & Sacks, P.C., Kirkland & Ellis LLP, Sterne Kessler, Nelson Mullins Riley & Scarborough LLP, Pabst Patent Group, Excelon IP, Pharma Patents International, J A Kemp, DLA Piper, Michael Best & Friedrich LLP, Troutman Pepper, Cooley LLP, Fish & Richardson
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Technology Focus etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical & Biotechnology IP Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Pharmaceutical & Biotechnology IP Services Market growing?

Ans: The Pharmaceutical & Biotechnology IP Services Market witnessing a CAGR of 8.6% during the forecast period 2025-2031.

What is the Pharmaceutical & Biotechnology IP Services Market size in 2031?

Ans: The Pharmaceutical & Biotechnology IP Services Market size in 2031 will be US$ 15699 million.

Who are the main players in the Pharmaceutical & Biotechnology IP Services Market report?

Ans: The main players in the Pharmaceutical & Biotechnology IP Services Market are Finnegan, MBHB, Wolf Greenfield & Sacks, P.C., Kirkland & Ellis LLP, Sterne Kessler, Nelson Mullins Riley & Scarborough LLP, Pabst Patent Group, Excelon IP, Pharma Patents International, J A Kemp, DLA Piper, Michael Best & Friedrich LLP, Troutman Pepper, Cooley LLP, Fish & Richardson

What are the Application segmentation covered in the Pharmaceutical & Biotechnology IP Services Market report?

Ans: The Applications covered in the Pharmaceutical & Biotechnology IP Services Market report are Pharmaceutical Companies, Contract Research Organizations (CROs), Others

What are the Type segmentation covered in the Pharmaceutical & Biotechnology IP Services Market report?

Ans: The Types covered in the Pharmaceutical & Biotechnology IP Services Market report are Patents, Copyrights, Trademarks, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pharmaceutical & Biotechnology IP Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Patents

1.2.3 Copyrights

1.2.4 Trademarks

1.2.5 Others

1.3 Market by Technology Focus

1.3.1 Global Pharmaceutical & Biotechnology IP Services Market Size Growth Rate by Technology Focus: 2020 VS 2024 VS 2031

1.3.2 Small Molecule Drugs

1.3.3 Biologics

1.3.4 Biosimilars

1.3.5 Gene Therapies

1.3.6 Diagnostics

1.3.7 Vaccines

1.3.8 Others

1.4 Market by Engagement Model

1.4.1 Global Pharmaceutical & Biotechnology IP Services Market Size Growth Rate by Engagement Model: 2020 VS 2024 VS 2031

1.4.2 Project-based

1.4.3 Petainer-based

1.4.4 Others

1.5 Market by Complexity and Technical Depth

1.5.1 Global Pharmaceutical & Biotechnology IP Services Market Size Growth Rate by Complexity and Technical Depth: 2020 VS 2024 VS 2031

1.5.2 Basic IP Services

1.5.3 Advanced IP Services

1.6 Market by Application

1.6.1 Global Pharmaceutical & Biotechnology IP Services Market Growth by Application: 2020 VS 2024 VS 2031

1.6.2 Pharmaceutical Companies

1.6.3 Contract Research Organizations (CROs)

1.6.4 Others

1.7 Assumptions and Limitations

1.8 Study Objectives

1.9 Years Considered

2 Global Growth Trends

2.1 Global Pharmaceutical & Biotechnology IP Services Market Perspective (2020-2031)

2.2 Global Pharmaceutical & Biotechnology IP Services Growth Trends by Region

2.2.1 Global Pharmaceutical & Biotechnology IP Services Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Pharmaceutical & Biotechnology IP Services Historic Market Size by Region (2020-2025)

2.2.3 Pharmaceutical & Biotechnology IP Services Forecasted Market Size by Region (2026-2031)

2.3 Pharmaceutical & Biotechnology IP Services Market Dynamics

2.3.1 Pharmaceutical & Biotechnology IP Services Industry Trends

2.3.2 Pharmaceutical & Biotechnology IP Services Market Drivers

2.3.3 Pharmaceutical & Biotechnology IP Services Market Challenges

2.3.4 Pharmaceutical & Biotechnology IP Services Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pharmaceutical & Biotechnology IP Services Players by Revenue

3.1.1 Global Top Pharmaceutical & Biotechnology IP Services Players by Revenue (2020-2025)

3.1.2 Global Pharmaceutical & Biotechnology IP Services Revenue Market Share by Players (2020-2025)

3.2 Global Top Pharmaceutical & Biotechnology IP Services Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Pharmaceutical & Biotechnology IP Services Revenue

3.4 Global Pharmaceutical & Biotechnology IP Services Market Concentration Ratio

3.4.1 Global Pharmaceutical & Biotechnology IP Services Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical & Biotechnology IP Services Revenue in 2024

3.5 Global Key Players of Pharmaceutical & Biotechnology IP Services Head office and Area Served

3.6 Global Key Players of Pharmaceutical & Biotechnology IP Services, Product and Application

3.7 Global Key Players of Pharmaceutical & Biotechnology IP Services, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmaceutical & Biotechnology IP Services Breakdown Data by Type

4.1 Global Pharmaceutical & Biotechnology IP Services Historic Market Size by Type (2020-2025)

4.2 Global Pharmaceutical & Biotechnology IP Services Forecasted Market Size by Type (2026-2031)

5 Pharmaceutical & Biotechnology IP Services Breakdown Data by Application

5.1 Global Pharmaceutical & Biotechnology IP Services Historic Market Size by Application (2020-2025)

5.2 Global Pharmaceutical & Biotechnology IP Services Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Pharmaceutical & Biotechnology IP Services Market Size (2020-2031)

6.2 North America Pharmaceutical & Biotechnology IP Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Pharmaceutical & Biotechnology IP Services Market Size by Country (2020-2025)

6.4 North America Pharmaceutical & Biotechnology IP Services Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Pharmaceutical & Biotechnology IP Services Market Size (2020-2031)

7.2 Europe Pharmaceutical & Biotechnology IP Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Pharmaceutical & Biotechnology IP Services Market Size by Country (2020-2025)

7.4 Europe Pharmaceutical & Biotechnology IP Services Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Pharmaceutical & Biotechnology IP Services Market Size (2020-2031)

8.2 Asia-Pacific Pharmaceutical & Biotechnology IP Services Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Pharmaceutical & Biotechnology IP Services Market Size by Region (2020-2025)

8.4 Asia-Pacific Pharmaceutical & Biotechnology IP Services Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Pharmaceutical & Biotechnology IP Services Market Size (2020-2031)

9.2 Latin America Pharmaceutical & Biotechnology IP Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Pharmaceutical & Biotechnology IP Services Market Size by Country (2020-2025)

9.4 Latin America Pharmaceutical & Biotechnology IP Services Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size (2020-2031)

10.2 Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size by Country (2020-2025)

10.4 Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Finnegan

11.1.1 Finnegan Company Details

11.1.2 Finnegan Business Overview

11.1.3 Finnegan Pharmaceutical & Biotechnology IP Services Introduction

11.1.4 Finnegan Revenue in Pharmaceutical & Biotechnology IP Services Business (2020-2025)

11.1.5 Finnegan Recent Development

11.2 MBHB

11.2.1 MBHB Company Details

11.2.2 MBHB Business Overview

11.2.3 MBHB Pharmaceutical & Biotechnology IP Services Introduction

11.2.4 MBHB Revenue in Pharmaceutical & Biotechnology IP Services Business (2020-2025)

11.2.5 MBHB Recent Development

11.3 Wolf Greenfield & Sacks, P.C.

11.3.1 Wolf Greenfield & Sacks, P.C. Company Details

11.3.2 Wolf Greenfield & Sacks, P.C. Business Overview

11.3.3 Wolf Greenfield & Sacks, P.C. Pharmaceutical & Biotechnology IP Services Introduction

11.3.4 Wolf Greenfield & Sacks, P.C. Revenue in Pharmaceutical & Biotechnology IP Services Business (2020-2025)

11.3.5 Wolf Greenfield & Sacks, P.C. Recent Development

11.4 Kirkland & Ellis LLP

11.4.1 Kirkland & Ellis LLP Company Details

11.4.2 Kirkland & Ellis LLP Business Overview

11.4.3 Kirkland & Ellis LLP Pharmaceutical & Biotechnology IP Services Introduction

11.4.4 Kirkland & Ellis LLP Revenue in Pharmaceutical & Biotechnology IP Services Business (2020-2025)

11.4.5 Kirkland & Ellis LLP Recent Development

11.5 Sterne Kessler

11.5.1 Sterne Kessler Company Details

11.5.2 Sterne Kessler Business Overview

11.5.3 Sterne Kessler Pharmaceutical & Biotechnology IP Services Introduction

11.5.4 Sterne Kessler Revenue in Pharmaceutical & Biotechnology IP Services Business (2020-2025)

11.5.5 Sterne Kessler Recent Development

11.6 Nelson Mullins Riley & Scarborough LLP

11.6.1 Nelson Mullins Riley & Scarborough LLP Company Details

11.6.2 Nelson Mullins Riley & Scarborough LLP Business Overview

11.6.3 Nelson Mullins Riley & Scarborough LLP Pharmaceutical & Biotechnology IP Services Introduction

11.6.4 Nelson Mullins Riley & Scarborough LLP Revenue in Pharmaceutical & Biotechnology IP Services Business (2020-2025)

11.6.5 Nelson Mullins Riley & Scarborough LLP Recent Development

11.7 Pabst Patent Group

11.7.1 Pabst Patent Group Company Details

11.7.2 Pabst Patent Group Business Overview

11.7.3 Pabst Patent Group Pharmaceutical & Biotechnology IP Services Introduction

11.7.4 Pabst Patent Group Revenue in Pharmaceutical & Biotechnology IP Services Business (2020-2025)

11.7.5 Pabst Patent Group Recent Development

11.8 Excelon IP

11.8.1 Excelon IP Company Details

11.8.2 Excelon IP Business Overview

11.8.3 Excelon IP Pharmaceutical & Biotechnology IP Services Introduction

11.8.4 Excelon IP Revenue in Pharmaceutical & Biotechnology IP Services Business (2020-2025)

11.8.5 Excelon IP Recent Development

11.9 Pharma Patents International

11.9.1 Pharma Patents International Company Details

11.9.2 Pharma Patents International Business Overview

11.9.3 Pharma Patents International Pharmaceutical & Biotechnology IP Services Introduction

11.9.4 Pharma Patents International Revenue in Pharmaceutical & Biotechnology IP Services Business (2020-2025)

11.9.5 Pharma Patents International Recent Development

11.10 J A Kemp

11.10.1 J A Kemp Company Details

11.10.2 J A Kemp Business Overview

11.10.3 J A Kemp Pharmaceutical & Biotechnology IP Services Introduction

11.10.4 J A Kemp Revenue in Pharmaceutical & Biotechnology IP Services Business (2020-2025)

11.10.5 J A Kemp Recent Development

11.11 DLA Piper

11.11.1 DLA Piper Company Details

11.11.2 DLA Piper Business Overview

11.11.3 DLA Piper Pharmaceutical & Biotechnology IP Services Introduction

11.11.4 DLA Piper Revenue in Pharmaceutical & Biotechnology IP Services Business (2020-2025)

11.11.5 DLA Piper Recent Development

11.12 Michael Best & Friedrich LLP

11.12.1 Michael Best & Friedrich LLP Company Details

11.12.2 Michael Best & Friedrich LLP Business Overview

11.12.3 Michael Best & Friedrich LLP Pharmaceutical & Biotechnology IP Services Introduction

11.12.4 Michael Best & Friedrich LLP Revenue in Pharmaceutical & Biotechnology IP Services Business (2020-2025)

11.12.5 Michael Best & Friedrich LLP Recent Development

11.13 Troutman Pepper

11.13.1 Troutman Pepper Company Details

11.13.2 Troutman Pepper Business Overview

11.13.3 Troutman Pepper Pharmaceutical & Biotechnology IP Services Introduction

11.13.4 Troutman Pepper Revenue in Pharmaceutical & Biotechnology IP Services Business (2020-2025)

11.13.5 Troutman Pepper Recent Development

11.14 Cooley LLP

11.14.1 Cooley LLP Company Details

11.14.2 Cooley LLP Business Overview

11.14.3 Cooley LLP Pharmaceutical & Biotechnology IP Services Introduction

11.14.4 Cooley LLP Revenue in Pharmaceutical & Biotechnology IP Services Business (2020-2025)

11.14.5 Cooley LLP Recent Development

11.15 Fish & Richardson

11.15.1 Fish & Richardson Company Details

11.15.2 Fish & Richardson Business Overview

11.15.3 Fish & Richardson Pharmaceutical & Biotechnology IP Services Introduction

11.15.4 Fish & Richardson Revenue in Pharmaceutical & Biotechnology IP Services Business (2020-2025)

11.15.5 Fish & Richardson Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Finnegan

Kirkland & Ellis LLP

Sterne Kessler

Nelson Mullins Riley & Scarborough LLP

Wolf Greenfield & Sacks, P.C.

Pharma Patents International

J A Kemp

Michael Best & Friedrich LLP

List of Tables

Table 1. Global Pharmaceutical & Biotechnology IP Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Patents

Table 3. Key Players of Copyrights

Table 4. Key Players of Trademarks

Table 5. Key Players of Others

Table 6. Global Pharmaceutical & Biotechnology IP Services Market Size Growth Rate by Technology Focus (US$ Million): 2020 VS 2024 VS 2031

Table 7. Key Players of Small Molecule Drugs

Table 8. Key Players of Biologics

Table 9. Key Players of Biosimilars

Table 10. Key Players of Gene Therapies

Table 11. Key Players of Diagnostics

Table 12. Key Players of Vaccines

Table 13. Key Players of Others

Table 14. Global Pharmaceutical & Biotechnology IP Services Market Size Growth Rate by Engagement Model (US$ Million): 2020 VS 2024 VS 2031

Table 15. Key Players of Project-based

Table 16. Key Players of Petainer-based

Table 17. Key Players of Others

Table 18. Global Pharmaceutical & Biotechnology IP Services Market Size Growth Rate by Complexity and Technical Depth (US$ Million): 2020 VS 2024 VS 2031

Table 19. Key Players of Basic IP Services

Table 20. Key Players of Advanced IP Services

Table 21. Global Pharmaceutical & Biotechnology IP Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 22. Global Pharmaceutical & Biotechnology IP Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 23. Global Pharmaceutical & Biotechnology IP Services Market Size by Region (2020-2025) & (US$ Million)

Table 24. Global Pharmaceutical & Biotechnology IP Services Market Share by Region (2020-2025)

Table 25. Global Pharmaceutical & Biotechnology IP Services Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 26. Global Pharmaceutical & Biotechnology IP Services Market Share by Region (2026-2031)

Table 27. Pharmaceutical & Biotechnology IP Services Market Trends

Table 28. Pharmaceutical & Biotechnology IP Services Market Drivers

Table 29. Pharmaceutical & Biotechnology IP Services Market Challenges

Table 30. Pharmaceutical & Biotechnology IP Services Market Restraints

Table 31. Global Pharmaceutical & Biotechnology IP Services Revenue by Players (2020-2025) & (US$ Million)

Table 32. Global Pharmaceutical & Biotechnology IP Services Market Share by Players (2020-2025)

Table 33. Global Top Pharmaceutical & Biotechnology IP Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical & Biotechnology IP Services as of 2024)

Table 34. Ranking of Global Top Pharmaceutical & Biotechnology IP Services Companies by Revenue (US$ Million) in 2024

Table 35. Global 5 Largest Players Market Share by Pharmaceutical & Biotechnology IP Services Revenue (CR5 and HHI) & (2020-2025)

Table 36. Global Key Players of Pharmaceutical & Biotechnology IP Services, Headquarters and Area Served

Table 37. Global Key Players of Pharmaceutical & Biotechnology IP Services, Product and Application

Table 38. Global Key Players of Pharmaceutical & Biotechnology IP Services, Date of Enter into This Industry

Table 39. Mergers & Acquisitions, Expansion Plans

Table 40. Global Pharmaceutical & Biotechnology IP Services Market Size by Type (2020-2025) & (US$ Million)

Table 41. Global Pharmaceutical & Biotechnology IP Services Revenue Market Share by Type (2020-2025)

Table 42. Global Pharmaceutical & Biotechnology IP Services Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 43. Global Pharmaceutical & Biotechnology IP Services Revenue Market Share by Type (2026-2031)

Table 44. Global Pharmaceutical & Biotechnology IP Services Market Size by Application (2020-2025) & (US$ Million)

Table 45. Global Pharmaceutical & Biotechnology IP Services Revenue Market Share by Application (2020-2025)

Table 46. Global Pharmaceutical & Biotechnology IP Services Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 47. Global Pharmaceutical & Biotechnology IP Services Revenue Market Share by Application (2026-2031)

Table 48. North America Pharmaceutical & Biotechnology IP Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. North America Pharmaceutical & Biotechnology IP Services Market Size by Country (2020-2025) & (US$ Million)

Table 50. North America Pharmaceutical & Biotechnology IP Services Market Size by Country (2026-2031) & (US$ Million)

Table 51. Europe Pharmaceutical & Biotechnology IP Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 52. Europe Pharmaceutical & Biotechnology IP Services Market Size by Country (2020-2025) & (US$ Million)

Table 53. Europe Pharmaceutical & Biotechnology IP Services Market Size by Country (2026-2031) & (US$ Million)

Table 54. Asia-Pacific Pharmaceutical & Biotechnology IP Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 55. Asia-Pacific Pharmaceutical & Biotechnology IP Services Market Size by Region (2020-2025) & (US$ Million)

Table 56. Asia-Pacific Pharmaceutical & Biotechnology IP Services Market Size by Region (2026-2031) & (US$ Million)

Table 57. Latin America Pharmaceutical & Biotechnology IP Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 58. Latin America Pharmaceutical & Biotechnology IP Services Market Size by Country (2020-2025) & (US$ Million)

Table 59. Latin America Pharmaceutical & Biotechnology IP Services Market Size by Country (2026-2031) & (US$ Million)

Table 60. Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 61. Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size by Country (2020-2025) & (US$ Million)

Table 62. Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size by Country (2026-2031) & (US$ Million)

Table 63. Finnegan Company Details

Table 64. Finnegan Business Overview

Table 65. Finnegan Pharmaceutical & Biotechnology IP Services Product

Table 66. Finnegan Revenue in Pharmaceutical & Biotechnology IP Services Business (2020-2025) & (US$ Million)

Table 67. Finnegan Recent Development

Table 68. MBHB Company Details

Table 69. MBHB Business Overview

Table 70. MBHB Pharmaceutical & Biotechnology IP Services Product

Table 71. MBHB Revenue in Pharmaceutical & Biotechnology IP Services Business (2020-2025) & (US$ Million)

Table 72. MBHB Recent Development

Table 73. Wolf Greenfield & Sacks, P.C. Company Details

Table 74. Wolf Greenfield & Sacks, P.C. Business Overview

Table 75. Wolf Greenfield & Sacks, P.C. Pharmaceutical & Biotechnology IP Services Product

Table 76. Wolf Greenfield & Sacks, P.C. Revenue in Pharmaceutical & Biotechnology IP Services Business (2020-2025) & (US$ Million)

Table 77. Wolf Greenfield & Sacks, P.C. Recent Development

Table 78. Kirkland & Ellis LLP Company Details

Table 79. Kirkland & Ellis LLP Business Overview

Table 80. Kirkland & Ellis LLP Pharmaceutical & Biotechnology IP Services Product

Table 81. Kirkland & Ellis LLP Revenue in Pharmaceutical & Biotechnology IP Services Business (2020-2025) & (US$ Million)

Table 82. Kirkland & Ellis LLP Recent Development

Table 83. Sterne Kessler Company Details

Table 84. Sterne Kessler Business Overview

Table 85. Sterne Kessler Pharmaceutical & Biotechnology IP Services Product

Table 86. Sterne Kessler Revenue in Pharmaceutical & Biotechnology IP Services Business (2020-2025) & (US$ Million)

Table 87. Sterne Kessler Recent Development

Table 88. Nelson Mullins Riley & Scarborough LLP Company Details

Table 89. Nelson Mullins Riley & Scarborough LLP Business Overview

Table 90. Nelson Mullins Riley & Scarborough LLP Pharmaceutical & Biotechnology IP Services Product

Table 91. Nelson Mullins Riley & Scarborough LLP Revenue in Pharmaceutical & Biotechnology IP Services Business (2020-2025) & (US$ Million)

Table 92. Nelson Mullins Riley & Scarborough LLP Recent Development

Table 93. Pabst Patent Group Company Details

Table 94. Pabst Patent Group Business Overview

Table 95. Pabst Patent Group Pharmaceutical & Biotechnology IP Services Product

Table 96. Pabst Patent Group Revenue in Pharmaceutical & Biotechnology IP Services Business (2020-2025) & (US$ Million)

Table 97. Pabst Patent Group Recent Development

Table 98. Excelon IP Company Details

Table 99. Excelon IP Business Overview

Table 100. Excelon IP Pharmaceutical & Biotechnology IP Services Product

Table 101. Excelon IP Revenue in Pharmaceutical & Biotechnology IP Services Business (2020-2025) & (US$ Million)

Table 102. Excelon IP Recent Development

Table 103. Pharma Patents International Company Details

Table 104. Pharma Patents International Business Overview

Table 105. Pharma Patents International Pharmaceutical & Biotechnology IP Services Product

Table 106. Pharma Patents International Revenue in Pharmaceutical & Biotechnology IP Services Business (2020-2025) & (US$ Million)

Table 107. Pharma Patents International Recent Development

Table 108. J A Kemp Company Details

Table 109. J A Kemp Business Overview

Table 110. J A Kemp Pharmaceutical & Biotechnology IP Services Product

Table 111. J A Kemp Revenue in Pharmaceutical & Biotechnology IP Services Business (2020-2025) & (US$ Million)

Table 112. J A Kemp Recent Development

Table 113. DLA Piper Company Details

Table 114. DLA Piper Business Overview

Table 115. DLA Piper Pharmaceutical & Biotechnology IP Services Product

Table 116. DLA Piper Revenue in Pharmaceutical & Biotechnology IP Services Business (2020-2025) & (US$ Million)

Table 117. DLA Piper Recent Development

Table 118. Michael Best & Friedrich LLP Company Details

Table 119. Michael Best & Friedrich LLP Business Overview

Table 120. Michael Best & Friedrich LLP Pharmaceutical & Biotechnology IP Services Product

Table 121. Michael Best & Friedrich LLP Revenue in Pharmaceutical & Biotechnology IP Services Business (2020-2025) & (US$ Million)

Table 122. Michael Best & Friedrich LLP Recent Development

Table 123. Troutman Pepper Company Details

Table 124. Troutman Pepper Business Overview

Table 125. Troutman Pepper Pharmaceutical & Biotechnology IP Services Product

Table 126. Troutman Pepper Revenue in Pharmaceutical & Biotechnology IP Services Business (2020-2025) & (US$ Million)

Table 127. Troutman Pepper Recent Development

Table 128. Cooley LLP Company Details

Table 129. Cooley LLP Business Overview

Table 130. Cooley LLP Pharmaceutical & Biotechnology IP Services Product

Table 131. Cooley LLP Revenue in Pharmaceutical & Biotechnology IP Services Business (2020-2025) & (US$ Million)

Table 132. Cooley LLP Recent Development

Table 133. Fish & Richardson Company Details

Table 134. Fish & Richardson Business Overview

Table 135. Fish & Richardson Pharmaceutical & Biotechnology IP Services Product

Table 136. Fish & Richardson Revenue in Pharmaceutical & Biotechnology IP Services Business (2020-2025) & (US$ Million)

Table 137. Fish & Richardson Recent Development

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

Table 141. Authors List of This Report

List of Figures

Figure 1. Pharmaceutical & Biotechnology IP Services Picture

Figure 2. Global Pharmaceutical & Biotechnology IP Services Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Pharmaceutical & Biotechnology IP Services Market Share by Type: 2024 VS 2031

Figure 4. Patents Features

Figure 5. Copyrights Features

Figure 6. Trademarks Features

Figure 7. Others Features

Figure 8. Global Pharmaceutical & Biotechnology IP Services Market Size Comparison by Technology Focus (2020-2031) & (US$ Million)

Figure 9. Small Molecule Drugs Features

Figure 10. Biologics Features

Figure 11. Biosimilars Features

Figure 12. Gene Therapies Features

Figure 13. Diagnostics Features

Figure 14. Vaccines Features

Figure 15. Others Features

Figure 16. Global Pharmaceutical & Biotechnology IP Services Market Size Comparison by Engagement Model (2020-2031) & (US$ Million)

Figure 17. Project-based Features

Figure 18. Petainer-based Features

Figure 19. Others Features

Figure 20. Global Pharmaceutical & Biotechnology IP Services Market Size Comparison by Complexity and Technical Depth (2020-2031) & (US$ Million)

Figure 21. Basic IP Services Features

Figure 22. Advanced IP Services Features

Figure 23. Global Pharmaceutical & Biotechnology IP Services Market Size by Application (2020-2031) & (US$ Million)

Figure 24. Global Pharmaceutical & Biotechnology IP Services Market Share by Application: 2024 VS 2031

Figure 25. Pharmaceutical Companies Case Studies

Figure 26. Contract Research Organizations (CROs) Case Studies

Figure 27. Others Case Studies

Figure 28. Pharmaceutical & Biotechnology IP Services Report Years Considered

Figure 29. Global Pharmaceutical & Biotechnology IP Services Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 30. Global Pharmaceutical & Biotechnology IP Services Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 31. Global Pharmaceutical & Biotechnology IP Services Market Share by Region: 2024 VS 2031

Figure 32. Global Pharmaceutical & Biotechnology IP Services Market Share by Players in 2024

Figure 33. Global Pharmaceutical & Biotechnology IP Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 34. The Top 10 and 5 Players Market Share by Pharmaceutical & Biotechnology IP Services Revenue in 2024

Figure 35. North America Pharmaceutical & Biotechnology IP Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. North America Pharmaceutical & Biotechnology IP Services Market Share by Country (2020-2031)

Figure 37. United States Pharmaceutical & Biotechnology IP Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Canada Pharmaceutical & Biotechnology IP Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Europe Pharmaceutical & Biotechnology IP Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Europe Pharmaceutical & Biotechnology IP Services Market Share by Country (2020-2031)

Figure 41. Germany Pharmaceutical & Biotechnology IP Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. France Pharmaceutical & Biotechnology IP Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. U.K. Pharmaceutical & Biotechnology IP Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Italy Pharmaceutical & Biotechnology IP Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Russia Pharmaceutical & Biotechnology IP Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Ireland Pharmaceutical & Biotechnology IP Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Asia-Pacific Pharmaceutical & Biotechnology IP Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Asia-Pacific Pharmaceutical & Biotechnology IP Services Market Share by Region (2020-2031)

Figure 49. China Pharmaceutical & Biotechnology IP Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Japan Pharmaceutical & Biotechnology IP Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. South Korea Pharmaceutical & Biotechnology IP Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Southeast Asia Pharmaceutical & Biotechnology IP Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. India Pharmaceutical & Biotechnology IP Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. Australia & New Zealand Pharmaceutical & Biotechnology IP Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. Latin America Pharmaceutical & Biotechnology IP Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 56. Latin America Pharmaceutical & Biotechnology IP Services Market Share by Country (2020-2031)

Figure 57. Mexico Pharmaceutical & Biotechnology IP Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 58. Brazil Pharmaceutical & Biotechnology IP Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 59. Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 60. Middle East & Africa Pharmaceutical & Biotechnology IP Services Market Share by Country (2020-2031)

Figure 61. Israel Pharmaceutical & Biotechnology IP Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 62. Saudi Arabia Pharmaceutical & Biotechnology IP Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 63. UAE Pharmaceutical & Biotechnology IP Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 64. Finnegan Revenue Growth Rate in Pharmaceutical & Biotechnology IP Services Business (2020-2025)

Figure 65. MBHB Revenue Growth Rate in Pharmaceutical & Biotechnology IP Services Business (2020-2025)

Figure 66. Wolf Greenfield & Sacks, P.C. Revenue Growth Rate in Pharmaceutical & Biotechnology IP Services Business (2020-2025)

Figure 67. Kirkland & Ellis LLP Revenue Growth Rate in Pharmaceutical & Biotechnology IP Services Business (2020-2025)

Figure 68. Sterne Kessler Revenue Growth Rate in Pharmaceutical & Biotechnology IP Services Business (2020-2025)

Figure 69. Nelson Mullins Riley & Scarborough LLP Revenue Growth Rate in Pharmaceutical & Biotechnology IP Services Business (2020-2025)

Figure 70. Pabst Patent Group Revenue Growth Rate in Pharmaceutical & Biotechnology IP Services Business (2020-2025)

Figure 71. Excelon IP Revenue Growth Rate in Pharmaceutical & Biotechnology IP Services Business (2020-2025)

Figure 72. Pharma Patents International Revenue Growth Rate in Pharmaceutical & Biotechnology IP Services Business (2020-2025)

Figure 73. J A Kemp Revenue Growth Rate in Pharmaceutical & Biotechnology IP Services Business (2020-2025)

Figure 74. DLA Piper Revenue Growth Rate in Pharmaceutical & Biotechnology IP Services Business (2020-2025)

Figure 75. Michael Best & Friedrich LLP Revenue Growth Rate in Pharmaceutical & Biotechnology IP Services Business (2020-2025)

Figure 76. Troutman Pepper Revenue Growth Rate in Pharmaceutical & Biotechnology IP Services Business (2020-2025)

Figure 77. Cooley LLP Revenue Growth Rate in Pharmaceutical & Biotechnology IP Services Business (2020-2025)

Figure 78. Fish & Richardson Revenue Growth Rate in Pharmaceutical & Biotechnology IP Services Business (2020-2025)

Figure 79. Bottom-up and Top-down Approaches for This Report

Figure 80. Data Triangulation

Figure 81. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions